POINT Biopharma was founded in 2018 with the mission to develop and commercialize small molecule drugs that target proteins with large therapeutic opportunities and are differentiated from existing therapies. The company is led by a group of pioneering scientists and executives with extensive experience in drug development and commercialization.
